Sachs, Stephan
Bastidas-Ponce, Aimée
Tritschler, Sophie
Bakhti, Mostafa http://orcid.org/0000-0002-2307-1122
Böttcher, Anika
Sánchez-Garrido, Miguel A.
Tarquis-Medina, Marta
Kleinert, Maximilian
Fischer, Katrin
Jall, Sigrid
Harger, Alexandra
Bader, Erik
Roscioni, Sara
Ussar, Siegfried http://orcid.org/0000-0001-7575-0920
Feuchtinger, Annette
Yesildag, Burcak
Neelakandhan, Aparna
Jensen, Christine B.
Cornu, Marion
Yang, Bin
Finan, Brian http://orcid.org/0000-0002-6467-0447
DiMarchi, Richard D.
Tschöp, Matthias H. http://orcid.org/0000-0002-4744-371X
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
Hofmann, Susanna M. http://orcid.org/0000-0001-7682-5840
Müller, Timo D. http://orcid.org/0000-0002-0624-9339
Lickert, Heiko http://orcid.org/0000-0002-4597-8825
Article History
Received: 31 July 2019
Accepted: 15 January 2020
First Online: 20 February 2020
Change Date: 14 April 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42255-020-0201-1
Competing interests
: C.B.J., M.C., B.Y, B.F., and R.D.D. are current employees of Novo Nordisk. Novo Nordisk has licensed from Indiana University intellectual property pertaining to this report. M.H.T. serves as a scientific advisory board member of ERX Pharmaceuticals, Inc., Cambridge, MA. F.J.T. reports receiving consulting fees from Roche Diagnostics GmbH and Cellarity Inc., and ownership interest in Cellarity, Inc. and Dermagnostix. S.T. reports receiving consulting fees from Cellarity, Inc. The Institute for Diabetes and Obesity receives research support from Novo Nordisk. All other authors declare no conflict of interest.